Measures
toxicity, toxicities, Cancer
DISEASES, CANCER
Demographics, including age, sex, ethnicity, and race, were collected as self-report measures. Cancer type and stage, history of prior chemotherapy, planned treatment, and physician-reported Karnofsky performance scoreSymptoms were evaluated with PRO-CTCAE to assess symptomatic toxicity and provide complementary data to CTCAE. During the design of the GAP 70+ study in 2013, the investigators selected 27 PRO-CTCAE symptoms on the basis of relevance to older adults and prevalence of treatment toxicities. The items were reviewed by the NCI, geriatric oncology experts in the Cancer and Aging Research Group,Core symptoms commonly occur across diseases and treatments.